HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Mario Poljak Selected Research
Mario Poljak Research Topics
Disease
32
Infections
06/2022 - 09/2002
19
Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2022 - 08/2009
16
Neoplasms (Cancer)
01/2021 - 12/2011
15
Papillomavirus Infections
01/2021 - 01/2005
11
Carcinoma (Carcinomatosis)
12/2020 - 09/2003
8
Papilloma (Papillomatosis)
10/2021 - 08/2012
7
Squamous Cell Carcinoma (Epidermoid Carcinoma)
10/2021 - 09/2003
7
Warts (Wart)
12/2016 - 01/2011
5
COVID-19
02/2022 - 01/2021
5
Squamous Cell Carcinoma of Head and Neck
11/2017 - 09/2003
5
Hepatitis C
05/2014 - 01/2003
5
Chronic Hepatitis C
01/2014 - 09/2002
4
Chronic Hepatitis B
06/2022 - 09/2002
3
Hepatitis
06/2022 - 10/2013
3
Communicable Diseases (Infectious Diseases)
01/2022 - 01/2018
3
Uterine Cervical Dysplasia
01/2022 - 11/2012
3
Recurrent respiratory papillomatosis
12/2014 - 09/2011
3
Viremia
02/2014 - 09/2002
3
Acquired Immunodeficiency Syndrome (AIDS)
01/2014 - 11/2004
3
Hepatitis B
10/2013 - 01/2004
3
Carcinogenesis
05/2009 - 09/2003
2
Condylomata Acuminata (Genital Wart)
01/2018 - 12/2013
2
Head and Neck Neoplasms (Head and Neck Cancer)
06/2016 - 12/2012
2
Anus Neoplasms (Anal Cancer)
01/2015 - 09/2011
2
Cardiovascular Diseases (Cardiovascular Disease)
01/2014 - 11/2004
2
HIV Infections (HIV Infection)
01/2014 - 01/2004
2
Disease Progression
06/2010 - 09/2002
2
Hyperplasia
03/2005 - 09/2003
1
Adenocarcinoma in Situ
10/2021
1
Critical Illness (Critically Ill)
01/2018
1
Adenocarcinoma
11/2017
1
Progressive Multifocal Leukoencephalopathy
03/2016
1
Pneumonia (Pneumonitis)
01/2015
1
Herpes Simplex Encephalitis (Herpes Encephalitis)
01/2015
1
Septic Shock (Toxic Shock Syndrome)
09/2014
1
Sepsis (Septicemia)
09/2014
1
Peripheral Arterial Disease
05/2014
1
Inflammation (Inflammations)
01/2014
1
Atherosclerosis
01/2014
Drug/Important Bio-Agent (IBA)
34
DNA (Deoxyribonucleic Acid)
IBA
01/2022 - 09/2002
22
Vaccines
IBA
02/2022 - 08/2009
12
Papillomavirus Vaccines (HPV Vaccines)
IBA
08/2021 - 11/2013
9
RNA (Ribonucleic Acid)
IBA
03/2021 - 11/2004
7
Messenger RNA (mRNA)
IBA
01/2022 - 09/2003
7
Antibodies
IBA
01/2021 - 04/2013
5
Biomarkers (Surrogate Marker)
IBA
01/2021 - 09/2003
4
Hepatitis B Surface Antigens (HBsAg)
FDA Link
06/2022 - 10/2013
4
Paraffin
IBA
06/2016 - 07/2011
4
Formaldehyde (Formol)
FDA Link
06/2016 - 07/2011
3
Indicators and Reagents (Reagents)
IBA
01/2022 - 01/2019
3
Antigens
IBA
01/2021 - 02/2005
3
Ribavirin (Virazole)
FDA Link
Generic
05/2014 - 02/2005
3
Interferon-alpha (Interferon Alfa)
IBA
10/2013 - 09/2002
3
Telomerase (Telomerase Reverse Transcriptase)
IBA
11/2005 - 09/2003
2
Hepatitis B e Antigens
IBA
09/2018 - 10/2013
2
Cisplatin (Platino)
FDA Link
Generic
01/2018 - 11/2014
2
Viral Proteins
IBA
11/2017 - 03/2016
2
Cyclin-Dependent Kinase Inhibitor p16
IBA
06/2016 - 01/2015
2
Nucleic Acids
IBA
03/2016 - 02/2005
2
Antiviral Agents (Antivirals)
IBA
01/2015 - 09/2002
2
beta-Globins (beta Globin)
IBA
01/2015 - 08/2009
2
Reverse Transcriptase Inhibitors
IBA
07/2014 - 04/2011
2
Interferons
IBA
05/2014 - 01/2014
2
Combined Vaccines
IBA
08/2012 - 09/2011
2
Proteins (Proteins, Gene)
FDA Link
04/2011 - 03/2005
2
Enzymes
IBA
12/2006 - 09/2003
2
cyclopropapyrroloindole
IBA
04/2005 - 01/2005
1
Surface Antigens (Surface Antigen)
IBA
06/2022
1
COVID-19 Vaccines
IBA
02/2022
1
2019-nCoV Vaccine mRNA-1273
IBA
02/2022
1
Silver
IBA
10/2021
1
Mucins
IBA
10/2021
1
Hepatitis C Antibodies
IBA
09/2020
1
Virulence Factors (Pathogenicity Factors)
IBA
09/2019
1
Terminator Codon (Termination Codon)
IBA
01/2018
1
Anti-Bacterial Agents (Antibiotics)
IBA
01/2018
1
Ozone
IBA
06/2017
1
nas
IBA
01/2016
1
entecavir
FDA Link
01/2016
1
Tenofovir (Viread)
FDA Link
01/2016
1
Fluorouracil (Carac)
FDA Link
Generic
11/2014
1
Docetaxel (Taxotere)
FDA Link
11/2014
1
Cetuximab (Erbitux)
FDA Link
11/2014
1
Nitrites
IBA
10/2014
1
Nucleosides
IBA
07/2014
1
N- (3- amino- 1- (cyclobutylmethyl)- 2,3- dioxopropyl)- 3- (2- ((((1,1- dimethylethyl)amino)carbonyl)amino)- 3,3- dimethyl- 1- oxobutyl)- 6,6- dimethyl- 3- azabicyclo(3.1.0)hexan- 2- carboxamide
IBA
05/2014
1
Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)
IBA
01/2014
1
C-Reactive Protein
IBA
01/2014
1
Fluvastatin
FDA Link
01/2014
1
Plasminogen Activator Inhibitor 1
IBA
01/2014
Therapy/Procedure
13
Therapeutics
09/2016 - 09/2002
3
Aftercare (After-Treatment)
08/2021 - 04/2011
3
Renal Dialysis (Hemodialysis)
12/2019 - 01/2003
2
Radiotherapy
01/2018 - 12/2011
2
Highly Active Antiretroviral Therapy (HAART)
01/2014 - 11/2004
1
Artificial Respiration (Mechanical Ventilation)
02/2022
1
Personal Protective Equipment
03/2021
1
Critical Care (Surgical Intensive Care)
01/2018
1
Induction Chemotherapy
11/2014
1
Liver Transplantation
05/2014